Company Filing History:
1 out of 7 
1 out of 1 Years Active: 2022
Title: Runqing Wang - Innovator in Pharmaceutical Inhibitors
Introduction
Runqing Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of inhibitors that target specific proteins. His work has the potential to impact the treatment of various diseases.
Latest Patents
Runqing Wang holds a patent for "Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereof." This patent describes compounds that possess a structure represented by formula (I). The invention details preparation methods for these compounds and their application as KRAS inhibitors. The compounds demonstrate an excellent ability to selectively inhibit KRAS, showcasing improved pharmacodynamic and pharmacokinetic performance, along with reduced toxic side effects.
Career Highlights
Throughout his career, Runqing Wang has worked with notable companies in the biopharmaceutical sector. He has been associated with Suzhou Zelgen Biopharmaceuticals Co., Ltd. and Shanghai Zelgen Pharmaceutical Technology Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Runqing Wang has collaborated with several professionals in his field, including Binhua Lv and Dawei Cui. These collaborations have likely enhanced his research and development efforts, leading to advancements in pharmaceutical inhibitors.
Conclusion
Runqing Wang is a distinguished inventor whose work in developing KRAS inhibitors represents a significant advancement in pharmaceutical research. His contributions are poised to make a meaningful impact in the medical field.